No takes yet. Share an insight, caveat, or question.
Randomized trial characterizes outcome measures in adult-onset myotonic dystrophy type 1, indicating sensitivity for clinical trials.
Iterbeke et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: